CXCR2 BINDENDE POLYPEPTIDE
Patent europeic · EP2638068 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP2638068
- Numer da la dumonda
- EP11785367
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 07-11-2011
- Publitgà
- 18-09-2013
- Concedì
- 26-12-2018
- Stritgà
- 30-11-2019
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C07K 16/28 (2006.01)
- Prioritad
- US 411083 P 08.11.2010
- Dumonda PCT
- PCT/EP2011/069571 07.11.2011
- Publicaziun PCT
- WO2012/062713 18.05.2012
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 17-06-2020
Stritgà, taxa betg pajada
Published in Swissreg on 17.06.2020
- 29-05-2019
Owner
- Owner
- Novartis AG, Lichtstrasse 35, 4056 Basel → Ablynx N.V., Technologiepark 21, 9052 Zwijnaarde, Belgium
Published in Swissreg on 29.05.2019
- 07-01-2019
Concedì
Published in Swissreg on 07.01.2019
Partidas
Inventur
BROWN, Zarin
West Sussex Sussex RH12 5AB, GB
BRADLEY, Michelle
West Sussex Sussex RH12 5AB, GB
VAN HEEKE, Gino
West Sussex Sussex RH12 5AB, GB
STEFFENSEN, Soren
B-9052 Zwijnaarde, BE
CROMIE, Karen
B-9052 Zwijnaarde, BE
DOMBRECHT, Bruno
B-9052 Zwijnaarde, BE
CHARLTON, Steven John
West Sussex Sussex RH12 5AB, GB
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.